Fibrogenic effect of wollastonite compared with asbestos dust and dusts containing quartz

Our plain-English summary of Fibrogenic effect of wollastonite compared with asbestos dust and dusts containing quartz, by E.E. McConnell (Occupational and Environmental Medicine, 1995).

The study

• Author: E.E. McConnell
• Journal: Occupational and Environmental Medicine
• Published: 1995;52(9):621
• Type of article: Comment, Letter
• Cited by: 2 articles, as counted by NIH iCite
• Read it: PubMed · Publisher · Free full text

In plain English

This is a letter to the editor, not a research study. The author commented on a 1994 paper by Cambelova and Juck that reported pulmonary fibrosis in rats after wollastonite was instilled into the windpipe (intratracheal instillation). The author noted that their own earlier long-term inhalation study of wollastonite in rats found no fibrosis or neoplasia. The author said the paper did not describe the non-fibrous particles in its crushed samples, the number of instillations, or any microscopic findings showing where in the lung the extra collagen was. The author described their own earlier attempt at instillation (20 mg per rat per week for 13 weeks). It was abandoned because of early deaths, which the author ascribed to severe acute bronchiolitis obliterans. The author added that intraperitoneal injection studies by Pott and colleagues produced no significant fibrosis or tumours. The author concluded that the paper probably produced a fibrogranulomatous bronchiolitis that would not occur after inhalation, and that it therefore had no relevance to wollastonite's health effects in humans.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: letter to the editor commenting on a published rat study (Cambelova and Juck, 1994); no new study reported
• Who was studied: No study population of its own. The letter discusses rats given wollastonite by intratracheal instillation in the Cambelova and Juck study, and rats in the author's own earlier wollastonite studies.
• Exposure: Wollastonite (samples described as wollastonite-China and wollastonite-NYCO, obtained by crushing), given to rats by intratracheal instillation; the author contrasts this with inhalation exposure.
• Main results:
  • The author reported that their own earlier long-term inhalation study of wollastonite in rats (10 mg/m3 for 6 hours a day, 5 days a week, for 12 months plus 12 months observation, or for a full 24 months) produced no fibrosis or neoplasia.
  • The author criticised the Cambelova and Juck report for not describing the non-fibrous particles in the injected sample and for not making clear how many instillations the rats received.
  • The author described their own earlier attempt at intratracheal instillation of wollastonite (20 mg per rat per week for 13 weeks), which was abandoned because of early deaths that the author ascribed to severe acute bronchiolitis obliterans. The author reported that the NYCO NYAD-G sample clumped and plugged small airways.
  • The author noted that Cambelova and Juck reported no histopathological findings, so the location of the increased collagen could not be determined.
  • The author stated that intraperitoneal injection studies by Pott and colleagues, using the same types and similar amounts (more than 20 mg) of wollastonite in rats, failed to produce a significant amount of fibrosis or tumours.
• The authors' conclusion: The author concluded that Cambelova and Juck probably produced a fibrogranulomatous bronchiolitis (probably occlusive) that would not have occurred if the fibres had been inhaled, and that their results therefore have no relevance for determining the potential health effects of wollastonite in humans.
• Limitations the authors state:
  • The author states that their own earlier instillation study did not include hydroxyproline (collagen) measurements.

Topics

Medical terms in this study, explained in our Lexicon: Fibrogenic, Wollastonite.

Related studies

• Fibrogenic effect of wollastonite compared with asbestos dust and dusts containing quartz — M. Cambelová, A. Juck (1994)
• Wollastonite exposure and lung fibrosis — M.S. Huuskonen, A. Tossavainen, et al. (1983)
• Pulmonary toxicity of wollastonite in vivo and in vitro — E. Tátrai, Z. Kováciková, et al. (2004)
• Red blood cell damage by wollastonite: in vitro study — M. Aslam, M.J. Arif, et al. (1995)
• Measurement of reactive oxygen metabolites produced by human monocyte-derived macrophages exposed to mineral dusts — P. Nyberg, M. Klockars (1990)
• Cytotoxicity of respirable dusts from industrial minerals: comparison of two naturally occurring and two man-made silicates — D. Nadeau, L. Fouquette-Couture, et al. (1987)

Browse more research in Occupational and Environmental Medicine, or return to medical research.